Ignite Creation Date:
2024-05-06 @ 8:00 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06216587
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-22
First Post:
2024-01-10
Brief Title:
BLa80 Improve Drinkers Gut Microbiota
Sponsor:
Wecare Probiotics Co Ltd
Organization:
Wecare Probiotics Co Ltd
Study Overview
Official Title:
A Randomized Double-blind Controlled Trial to Assess the Impact of BLa80 on the Intestinal Health of Individuals Who Consume Alcohol
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to understand the effects of the probiotic BLa80 on the gut health of people who drink alcohol regularly We want to find out if this probiotic can help improve the health of the digestive system in those who consume alcohol The main questions we aim to answer are Does BLa80 positively change the composition of gut bacteria in alcohol consumers Participants in this study will Be randomly assigned to one of two groups One group will receive the probiotic BLa80 and the other group will receive a placebo a substance with no active therapeutic effect Take their assigned treatment for a specified period as directed by the study protocol Undergo regular health checks and provide feceal samples for analysis to see how their gut bacteria might have changed during the study This study is important because it explores whether a specific type of probiotic can help protect or improve gut health in people who drink alcohol potentially offering a new way to support digestive health
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None